However, addition of IL-15 further increased the percentages of α-Galcer-treated NKT-like cells in SLE patients with active SLE disease, suggesting NKT-like cells from SLE patients with active disease are more readily activated by IL-15. Here, IL15 is linked to systemic lupus erythematosus.